Donato, Shirlyn C.
HRN: 04-41-24 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2024
CEFUROXIME 1.5GM (VIAL)
05/13/2024
05/14/2024
IV
1.5g
Q8
Tahbso
Waiting Final Action
05/14/2024
CEFUROXIME 500MG (TAB)
05/14/2024
05/20/2024
PO
500mg
BID
S/P TAHBSO
Waiting Final Action